HUS1100022I1 - 2-Amino-3-(4-bróm-benzoil)-fenilecetsavat tartalmazó vizes folyadék készítmény - Google Patents

2-Amino-3-(4-bróm-benzoil)-fenilecetsavat tartalmazó vizes folyadék készítmény

Info

Publication number: HUS1100022I1
Authority: HU; Hungary
Prior art keywords: aqueous liquid; liquid preparation; rhinitis; bromobenzoyl; amino
Prior art date: 2003-01-21

Application number

HUS1100022C

Other languages

English (en)

Original Assignee

Senju Pharma Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-01-21

Filing date

2011-11-04

Publication date

2017-04-28

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32767329&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HUS1100022(I1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2011-11-04 Application filed by Senju Pharma Co filed Critical Senju Pharma Co

2017-04-28 Publication of HUS1100022I1 publication Critical patent/HUS1100022I1/hu

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Inorganic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Engineering & Computer Science (AREA)
Ophthalmology & Optometry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Otolaryngology (AREA)
Bioinformatics & Cheminformatics (AREA)
Oil, Petroleum & Natural Gas (AREA)
Rheumatology (AREA)
Pain & Pain Management (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

HUS1100022C 2003-01-21 2011-11-04 2-Amino-3-(4-bróm-benzoil)-fenilecetsavat tartalmazó vizes folyadék készítmény HUS1100022I1 (hu)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
JP2003012427		2003-01-21

Publications (1)

Publication Number	Publication Date
HUS1100022I1 true HUS1100022I1 (hu)	2017-04-28

Family

ID=32767329

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
HUS1100022C HUS1100022I1 (hu)	2003-01-21	2011-11-04	2-Amino-3-(4-bróm-benzoil)-fenilecetsavat tartalmazó vizes folyadék készítmény

Country Status (15)

Country	Link
US (9)	US8129431B2 (hu)
EP (1)	EP1586316B1 (hu)
JP (1)	JP4500261B2 (hu)
KR (1)	KR101059711B1 (hu)
CN (1)	CN100341498C (hu)
AT (1)	ATE393627T1 (hu)
BE (1)	BE2011C027I2 (hu)
CA (2)	CA2944832C (hu)
DE (2)	DE122011100019I1 (hu)
ES (1)	ES2301964T3 (hu)
FR (1)	FR11C0031I2 (hu)
HU (1)	HUS1100022I1 (hu)
MX (1)	MX2016014404A (hu)
PT (1)	PT1586316E (hu)
WO (2)	WO2004064828A1 (hu)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6552020B1 (en) *	1999-07-30	2003-04-22	Allergan, Inc.	Compositions including antibiotics and methods for using same
KR101059711B1 (ko) *	2003-01-21	2011-08-29	센주 세이야꾸 가부시키가이샤	2-아미노-3-(4-브로모벤조일)페닐아세트산 함유 수성액제
JP4933897B2 (ja) *	2004-11-05	2012-05-16	千寿製薬株式会社	眼内移行性促進水性点眼剤
TWI358290B (en)	2004-12-02	2012-02-21	Alcon Inc	Topical nepafenac formulations
US20100130580A1 (en) *	2006-01-25	2010-05-27	Aciex Therapeutics, Inc.	Formulations and Methods for Treating Dry Eye
EP1981491A4 (en) *	2006-01-25	2009-09-23	Aciex Inc	COMPOSITIONS AND METHODS FOR TREATING OPHTHALMIC DROUGHT
AU2008219600A1 (en) *	2007-02-28	2008-09-04	Aciex Therapeutics, Inc.	Methods and compositions for normalizing meibomian gland secretions
EP2160182A1 (en) *	2007-05-24	2010-03-10	Aciex Therapeutics, Inc.	Formulations and methods for treating dry eye
CN101313899B (zh) *	2007-06-01	2012-02-29	北京德众万全药物技术开发有限公司	一种含有溴芬酸钠的眼用药物组合物
WO2009105534A2 (en) *	2008-02-21	2009-08-27	Ista Pharmaceuticals	Ophthalmic nsaids as adjuvants
DK2420223T3 (da) *	2008-03-17	2017-11-06	Novartis Ag	Vandige farmaceutiske sammensætninger med borat-polyol-komplekser
US8778999B2 (en) *	2009-03-05	2014-07-15	Insite Vision Incorporated	Non-steroidal anti-inflammatory ophthalmic compositions
TWI489997B (zh) *	2009-06-19	2015-07-01	Alcon Res Ltd	含有硼酸－多元醇錯合物之水性藥學組成物
GB2484843A (en) *	2009-10-15	2012-04-25	Johnson Matthey Plc	Polymorphs of Bromfenac sodium
US8299295B2 (en)	2009-10-15	2012-10-30	Johnson Matthey Public Limited Company	Polymorphs of bromfenac sodium and methods for preparing bromfenac sodium polymorphs
GB0919757D0 (en) *	2009-11-12	2009-12-30	Johnson Matthey Plc	Polymorphs of bromfenac sodium and methods for preparing bromfenac sodium polymorphs
EP2498768A1 (en) *	2009-11-11	2012-09-19	Micro Labs Limited	Pharmaceutical combination of prostaglandin compound and nsaid for the treatment of glaucoma and ocular hypertension
CN103379904A (zh) *	2011-01-18	2013-10-30	千寿制药株式会社	具有保存效能的溴芬酸水性液剂组合物
JP6012231B2 (ja) *	2011-04-08	2016-10-25	ロート製薬株式会社	ブロムフェナク含有組成物
EP2701682A1 (en)	2011-04-29	2014-03-05	Allergan, Inc.	Solvent cast film sustained release latanoprost implant
US20130023575A1 (en) *	2011-07-22	2013-01-24	Kamran Hosseini	Compositions and methods for the treatment of ocular surface allergies
ES2992712T3 (en)	2011-10-12	2024-12-17	Bausch & Lomb	Ocular composition containing bromfenac with increased bioavailability
US20130217657A1 (en) *	2011-12-21	2013-08-22	Insite Vision Incorporated	Combination anti-inflammatory ophthalmic compositions
US20130165419A1 (en) *	2011-12-21	2013-06-27	Insite Vision Incorporated	Combination anti-inflammatory ophthalmic compositions
CN104661682B (zh) *	2012-09-27	2018-05-11	千寿制药株式会社	水性液剂
JP6161500B2 (ja) *	2012-10-05	2017-07-12	ロート製薬株式会社	ブロムフェナク含有組成物
WO2014078766A1 (en)	2012-11-19	2014-05-22	Bausch & Lomb Incorporated	Aqueous liquid composition containing 2-amino-3-(4-bromobenzoyl)phenylacetic acid
WO2014120293A1 (en) *	2013-01-31	2014-08-07	Sentiss Pharma Pvt.Ltd.	Ophthalmic formulations
BR112015017919A8 (pt)	2013-01-31	2019-11-05	Senju Pharma Co	preparação líquida aquosa e método para clarificar uma preparação líquida aquosa
KR20150110775A (ko) *	2013-01-31	2015-10-02	센주 세이야꾸 가부시키가이샤	안정한 수성액제
US20160143869A1 (en)	2013-06-19	2016-05-26	Sentiss Research Center	Stable bromfenac solution
JP2015086222A (ja) *	2013-09-26	2015-05-07	参天製薬株式会社	安定化された２−アミノ−３−（４−ブロモベンゾイル）フェニル酢酸含有水性組成物
WO2015087267A2 (en) *	2013-12-12	2015-06-18	Sentiss Pharma Private Limited	Stable bromfenac ophthalmic solution
CN104151182B (zh) *	2014-06-16	2016-03-30	广东众生药业股份有限公司	一种溴芬酸钠倍半水合物的制备方法
US11452732B2 (en)	2015-09-05	2022-09-27	Randal Davis	Homogeneous ophthalmic composition
US10130639B1 (en)	2015-09-05	2018-11-20	Randal Davis	Homogeneous ophthalmic composition
CN106404952B (zh) *	2016-08-31	2019-06-11	辰欣佛都药业（汶上）有限公司	一种溴芬酸钠滴眼液有关物质的测定方法

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2880130A (en)	1956-12-24	1959-03-31	Upjohn Co	Anti-inflammatory steroid solutions
US2880138A (en)	1956-12-24	1959-03-31	Upjohn Co	Anti-inflammatory steroid solutions
SE400966B (sv) *	1975-08-13	1978-04-17	Robins Co Inc A H	Forfarande for framstellning av 2-amino-3-(eller 5-)bensoyl-fenylettiksyror
US4683242A (en)	1985-10-28	1987-07-28	A. H. Robins Company, Incorporated	Transdermal treatment for pain and inflammation with 2-amino-3-aroylbenzeneacetic acids, salts and esters
GB8630273D0 (en)	1986-12-18	1987-01-28	Til Medical Ltd	Pharmaceutical delivery systems
CA1328614C (en) *	1987-09-11	1994-04-19	Cherng-Chyi Roger Fu	Preservative system for ophthalmics formulations
US5414011A (en)	1987-09-11	1995-05-09	Syntex (U.S.A.) Inc.	Preservative system for ophthalmic formulations
US5110493A (en) *	1987-09-11	1992-05-05	Syntex (U.S.A.) Inc.	Ophthalmic NSAID formulations containing a quaternary ammonium preservative and a nonionic surfactant
CA1325382C (en) *	1988-01-27	1993-12-21	Takahiro Ogawa	Locally administrable therapeutic composition for inflammatory disease
JPH0283323A (ja) *	1988-09-20	1990-03-23	Zeria Pharmaceut Co Ltd	安定な酪酸リボフラビン水溶液
JPH02124819A (ja)	1988-11-01	1990-05-14	Mitsubishi Kasei Corp	経口コレステロール低下剤
JPH05223052A (ja)	1992-02-06	1993-08-31	Kanematsu Eng Kk	波浪エネルギ−を利用した電流発生装置及びこの電流発生装置が備えられた水素ガス発生装置
WO1994005298A1 (en)	1992-08-28	1994-03-17	Pharmos Corporation	Submicron emulsions as ocular drug delivery vehicles
AU6021794A (en)	1993-01-11	1994-08-15	Allergan, Inc.	Ophthalmic compositions comprising benzyllauryldimethylammonium chloride
US5540930A (en) *	1993-10-25	1996-07-30	Pharmos Corporation	Suspension of loteprednol etabonate for ear, eye, or nose treatment
LT3969B (en)	1994-03-15	1996-05-27	Senju Pharma Co	Method for stabilizing pranoprofen and stable liquid preparation of pranoprofen
ES2079320B1 (es) *	1994-05-17	1996-10-16	Cusi Lab	Disolucion oftalmica a base de un diclofenaco y tobramicina y sus aplicaciones.
US5475034A (en) *	1994-06-06	1995-12-12	Alcon Laboratories, Inc.	Topically administrable compositions containing 3-benzoylphenylacetic acid derivatives for treatment of ophthalmic inflammatory disorders
CA2201134A1 (en)	1994-10-10	1996-04-18	Alfred Sallmann	Ophthalmic and aural compositions containing diclofenac potassium
US5603929A (en) *	1994-11-16	1997-02-18	Alcon Laboratories, Inc.	Preserved ophthalmic drug compositions containing polymeric quaternary ammonium compounds
US5558876A (en) *	1995-03-29	1996-09-24	Alcon Laboratories, Inc.	Topical ophthalmic acidic drug formulations
US5750564A (en) *	1995-09-12	1998-05-12	Hellberg; Mark	Anti-oxidant esters of non-steroidal anti-inflammatory agents
US6071904A (en) *	1996-12-11	2000-06-06	Alcon Laboratories, Inc.	Process for manufacturing ophthalmic suspensions
US5942508A (en) *	1997-02-04	1999-08-24	Senju Pharmaceutical Co., Ltd.	Method for solubilizing pyridonecarboxylic acid solubilizer thereof and aqueous solution containing solubilized pyridonecarboxylic acid
US6274592B1 (en) *	1997-02-04	2001-08-14	Senju Pharmaceutical Co., Ltd.	Method for stabilizing arylcarboxylic acid, stabilizer thereof and aqueous solution containing stabilized arylcarboxylic acid
TW546151B (en)	1997-07-23	2003-08-11	Senju Pharma Co	Aqueous liquid pharmaceutical composition containing as main component benzopyran derivative
JPH11228404A (ja) *	1997-12-11	1999-08-24	Senju Pharmaceut Co Ltd	安定な水性点眼剤
US6066671A (en) *	1997-12-19	2000-05-23	Alcon Laboratories, Inc.	Treatment of GLC1A glaucoma with 3-benzoyl-phenylacetic acids, esters, or amides
US6162393A (en) *	1998-08-06	2000-12-19	Ndt, Inc.	Contact lens and ophthalmic solutions
US6319513B1 (en) *	1998-08-24	2001-11-20	The Procter & Gamble Company	Oral liquid mucoadhesive compounds
US6395746B1 (en) *	1998-09-30	2002-05-28	Alcon Manufacturing, Ltd.	Methods of treating ophthalmic, otic and nasal infections and attendant inflammation
US6369112B1 (en) *	1998-12-15	2002-04-09	Bausch & Lomb Incorporated	Treatment of contact lenses with aqueous solution comprising a biguanide disinfectant stabilized by tyloxapol
US6383471B1 (en) *	1999-04-06	2002-05-07	Lipocine, Inc.	Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents
WO2001015677A2 (en)	1999-08-31	2001-03-08	Alcon Laboratories, Inc.	Use of 5-ht1b/1d agonists to treat otic pain
NZ517556A (en)	1999-09-06	2003-08-29	Ono Pharmaceutical Co	N-[o-(p-pivaloyloxybenzenesulphonyl-amino)benzoyl]glycine as preventive and therapeutic agents for eye diseases
AR030345A1 (es)	2000-08-14	2003-08-20	Alcon Inc	Metodo de tratamiento de desordenes relacionados con angiogenesis
JP2002308764A (ja) *	2001-02-09	2002-10-23	Taisho Pharmaceut Co Ltd	眼科用医薬組成物
KR101059711B1 (ko) *	2003-01-21	2011-08-29	센주 세이야꾸 가부시키가이샤	2-아미노-3-(4-브로모벤조일)페닐아세트산 함유 수성액제
ATE552838T1 (de) *	2003-11-14	2012-04-15	Senju Pharma Co	Wässrige lösung mit aminoglykosid-antibiotikum und bromfenac
JP5223052B2 (ja)	2010-05-21	2013-06-26	春誠鈴木	コーキングガン
ES2992712T3 (en) *	2011-10-12	2024-12-17	Bausch & Lomb	Ocular composition containing bromfenac with increased bioavailability
WO2014078766A1 (en) *	2012-11-19	2014-05-22	Bausch & Lomb Incorporated	Aqueous liquid composition containing 2-amino-3-(4-bromobenzoyl)phenylacetic acid

2004
- 2004-01-16 KR KR1020057004667A patent/KR101059711B1/ko not_active Expired - Fee Related
- 2004-01-16 WO PCT/JP2004/000350 patent/WO2004064828A1/ja not_active Ceased
- 2004-01-16 US US10/525,006 patent/US8129431B2/en not_active Expired - Lifetime
- 2004-01-16 PT PT04702854T patent/PT1586316E/pt unknown
- 2004-01-16 JP JP2005508062A patent/JP4500261B2/ja not_active Expired - Fee Related
- 2004-01-16 ES ES04702854T patent/ES2301964T3/es not_active Expired - Lifetime
- 2004-01-16 DE DE201112100019 patent/DE122011100019I1/de active Pending
- 2004-01-16 AT AT04702854T patent/ATE393627T1/de active
- 2004-01-16 EP EP04702854A patent/EP1586316B1/en not_active Expired - Lifetime
- 2004-01-16 CN CNB2004800009763A patent/CN100341498C/zh not_active Expired - Lifetime
- 2004-01-16 DE DE602004013420T patent/DE602004013420T2/de not_active Expired - Lifetime
2007
- 2007-05-30 US US11/755,662 patent/US20070287749A1/en not_active Abandoned
2011
- 2011-08-17 FR FR11C0031C patent/FR11C0031I2/fr active Active
- 2011-08-30 BE BE2011C027C patent/BE2011C027I2/fr unknown
- 2011-11-04 HU HUS1100022C patent/HUS1100022I1/hu unknown
2012
- 2012-01-19 US US13/353,653 patent/US8497304B2/en not_active Expired - Fee Related
- 2012-11-28 US US13/687,242 patent/US8669290B2/en not_active Expired - Lifetime
2014
- 2014-01-28 US US14/165,976 patent/US8754131B2/en not_active Expired - Lifetime
- 2014-04-25 US US14/261,720 patent/US8871813B2/en not_active Expired - Lifetime
- 2014-05-05 US US14/269,692 patent/US9144609B2/en not_active Expired - Lifetime
- 2014-09-23 US US14/493,903 patent/US8927606B1/en not_active Expired - Lifetime
- 2014-09-30 US US14/502,014 patent/US9561277B2/en not_active Expired - Fee Related
2015
- 2015-05-05 CA CA2944832A patent/CA2944832C/en not_active Expired - Fee Related
- 2015-05-05 MX MX2016014404A patent/MX2016014404A/es unknown
- 2015-05-05 WO PCT/IB2015/000887 patent/WO2015170177A1/en not_active Ceased
- 2015-05-05 CA CA3043910A patent/CA3043910A1/en not_active Abandoned

Also Published As

Publication number	Publication date
FR11C0031I2 (fr)	2012-03-16
US20140243413A1 (en)	2014-08-28
DE122011100019I1 (de)	2011-11-03
CN1700913A (zh)	2005-11-23
KR101059711B1 (ko)	2011-08-29
US9144609B2 (en)	2015-09-29
WO2004064828A1 (ja)	2004-08-05
EP1586316B1 (en)	2008-04-30
US8927606B1 (en)	2015-01-06
US8497304B2 (en)	2013-07-30
US20150025149A1 (en)	2015-01-22
ATE393627T1 (de)	2008-05-15
CA3043910A1 (en)	2015-11-12
KR20050092691A (ko)	2005-09-22
DE602004013420T2 (de)	2009-06-04
CA2944832C (en)	2019-10-08
US20050239895A1 (en)	2005-10-27
US20140235721A1 (en)	2014-08-21
US20070287749A1 (en)	2007-12-13
US20140142183A1 (en)	2014-05-22
CN100341498C (zh)	2007-10-10
US20130090384A1 (en)	2013-04-11
JPWO2004064828A1 (ja)	2006-05-18
WO2015170177A1 (en)	2015-11-12
US8129431B2 (en)	2012-03-06
DE602004013420D1 (de)	2008-06-12
HK1083468A1 (en)	2006-07-07
BE2011C027I2 (hu)	2023-03-07
US8754131B2 (en)	2014-06-17
EP1586316A1 (en)	2005-10-19
ES2301964T3 (es)	2008-07-01
MX2016014404A (es)	2017-10-27
US20150011634A1 (en)	2015-01-08
JP4500261B2 (ja)	2010-07-14
US20120115957A1 (en)	2012-05-10
PT1586316E (pt)	2008-05-28
US8871813B2 (en)	2014-10-28
US8669290B2 (en)	2014-03-11
CA2944832A1 (en)	2015-11-12
EP1586316A4 (en)	2007-06-27
US9561277B2 (en)	2017-02-07

Publication	Publication Date	Title
HUS1100022I1 (hu)	2017-04-28	2-Amino-3-(4-bróm-benzoil)-fenilecetsavat tartalmazó vizes folyadék készítmény
RU2010139958A (ru)	2012-04-10	Стабилизированная фармацевтическая композиция, cодержащая доцетаксель
FR18C1027I1 (fr)	2018-08-17	Composition fongicide contenant un derive d'amide d'acide
CY1112401T1 (el)	2015-12-09	Παραγωγα πυριδαζινης
ATE532797T1 (de)	2011-11-15	Polymerisierbare zusammensetzungen enthaltend salze aus barbitursäure-derivaten
NO20044406L (no)	2002-05-22	Stabilisert flytende farmasoytisk sammensetning samt fremgangsmate for a oke stabiliteten av IL-2
ATE409458T1 (de)	2008-10-15	Flüssige darreichungsformen zur prävention und zur behandlung von schleimhautaffektionen
EP2189481A4 (en)	2010-12-15	FLUOROUS POLYMER AND THIS SURFACE MODULE IN THE ACTIVE SUBSTANCE
RU2011101713A (ru)	2012-07-27	Фармацевтическая композиция
BR112015005995A2 (pt)	2017-07-04	formulações líquidas de apixaban
CY1116189T1 (el)	2017-02-08	Σταθερη υγρη φαρμακευτικη συνθεση με βαση την τραζοδονη
IS8231A (is)	2006-01-13	Lyfjafræðilega gagnleg sölt karboxýlsýruafleiða
EA200501789A1 (ru)	2006-06-30	Стабильный водный раствор эритропоэтина человека, не содержащий сывороточного альбумина
DK1459739T3 (da)	2008-05-19	Ikke-hydroskopiske farmaceutiske sammensætninger indeholdende ikke-hydratiserede quinolin-carboxylsyrer
DE602004009573D1 (de)	2007-11-29	Herstellung von 5-methyl-dihydrofuran-2-on aus levulinsäure in superkritischen medien
MA30600B1 (fr)	2009-07-01	Formulation medicamenteuse aqueuse d'acide 4-[((4-carboxybutyl)-{2-[(4-phenethyl-benzyl)oxy]-phenethyl}amino)methyl]benzoique.
RU2012117141A (ru)	2013-11-10	Композиции олопатадина и способы их применения
EA201490127A1 (ru)	2014-04-30	Офтальмологический раствор, содержащий гиалуроновую кислоту или ее соль и пропиленгликоль
CY1112285T1 (el)	2015-12-09	Υγρες φαρμακοτεχνικες μορφες αλατων 4-[2-(4-μεθυλφαινυλσουλφανυλ)φαινυλ]πιπεριδινης
WO2015087267A3 (en)	2015-11-12	Stable bromfenac ophthalmic solution
EA201591910A1 (ru)	2016-05-31	Стабильный раствор бромфенака
EP2284211A4 (en)	2011-11-16	WATER-CONTAINING EMULSION WITH AN A-OLEFIN - / (METH) ACRYLATE COPOLYMER AND METHOD FOR THE PRODUCTION THEREOF
JP4820648B2 (ja)	2011-11-24	ロテプレドノールエタボネート水性懸濁液剤
EA201791191A1 (ru)	2017-12-29	Водные фармацевтические композиции для местного применения в ротовой полости, содержащие флурбипрофен и декспантенол
WO2022113970A1 (ja)	2022-06-02	涙液層破壊時間短縮型ドライアイ治療剤および該治療剤を含む点眼剤